期刊文献+

硫酸镁联合拉贝洛尔治疗妊高症的效果观察

Effect of Magnesium Sulfate Combined with Rabeprolol on Pregnancy-induced Hypertension
下载PDF
导出
摘要 目的观察拉贝洛尔联合硫酸镁治疗妊高症的临床价值。方法随机将2017年5月~2018年5月收治的70例妊高症患者分为两组,每组35例。对照组行硫酸镁治疗,观察组在对照组的基础上行拉贝洛尔治疗;比较两组临床疗效。结果观察组总有效率、血压水平以及母婴结局等指标明显优于对照组(P<0.05)。结论拉贝洛尔联合硫酸镁治疗妊高症效果显著,有利于改善母婴结局,提高了临床疗效。 Objective To observe the clinical value of labetalol combined with magnesium sulfate in the treatment of pregnancy induced hypertension. Methods Seventy patients with pregnancy-induced hypertension admitted to our hospital from May 2017 to May 2018 were randomly divided into two groups, 35 in each group. The control group was treated with magnesium sulfate, and the observation group was treated with basic aspirinol in the control group;the clinical efficacy of the two groups was compared. Results The total effective rate, blood pressure level and maternal and infant outcomes of the observation group were significantly better than the control group(P<0.05). Conclusions Labetalol combined with magnesium sulfate is effective in the treatment of pregnancy-induced hypertension, which is beneficial to improve maternal and infant outcomes and improve clinical efficacy. It is worthy of popularization and application.
作者 焦静 JIAO Jing(Obstetrics and Gynecology Department of Zhengzhou Seventh People rs Hospital,450000)
出处 《航空航天医学杂志》 2020年第1期9-10,共2页 Journal of Aerospace medicine
关键词 拉贝洛尔 硫酸镁 妊高症 妊娠结局 labetalol magnesium sulfate pregnancy-induced hypertension pregnancy outcome
  • 相关文献

二级参考文献73

  • 1黄培华,乔渝.联合应用硫酸镁和拉贝洛尔治疗妊娠期高血压的临床疗效分析[J].当代医药论丛,2014,12(6):144-145. 被引量:19
  • 2张艳萍,叶卫莲.115例妊娠高血压综合征的相关因素分析[J].中国全科医学,2005,8(4):308-309. 被引量:22
  • 3谢辛,苟文丽主编.妇产科学[M].第8版.北京:人民卫生出版社,2013:326-328.
  • 4American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy [J]. Obstet Gynecol, 2013, 122(5):1122-1131.
  • 5Magee LA, Pels A, Helewa M, et al.Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. J Obstet Gynaecol Can, 2014, 36(5):416-441.
  • 6Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance[J]. BMJ, 2010, 341 :c2207.
  • 7Lowe SA, Bowyer L, Lust K, et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014[J]. Aust N Z J Obstet Gynaecol, 2015, 55(1):11-16.
  • 8Campos-Outcah D Sr. US Preventive Services Task Force: the gold standard of evidence-based prevention[J]. J Fam Pract, 2005, 54(6):517-519.
  • 9Magee LA, Hdewa M, Momquin JM, et al. Diagnosis, evaluation,and management of the hypertensive disorders of pregnancy[J]. J Obstet Gynaeeol Can, 2008, 30 (Suppl): S1-48.
  • 10Cote AM, Brown MA, Laln E, et al. Diagnostic accuracy of urinary spot protein: creatiniue ratio for proteinuria in hypertensive pregnant women: systematic review[J]. BMJ, 2008, 336(7651): 1003-1006.

共引文献1288

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部